Macquarie Park, Australia

Matthew Pollard

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Dural, AU (2013 - 2021)
  • Pullenvale, AU (2021 - 2023)
  • Macquarie Park, AU (2014 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations by Inventor Matthew Pollard

Introduction

Matthew Pollard is an accomplished inventor based in Macquarie Park, Australia. With a remarkable portfolio that includes 18 patents, Pollard has made significant contributions to the field of biotechnology. His work primarily focuses on developing antibody-based therapies for various gastrointestinal and respiratory diseases.

Latest Patents

Among Pollard's latest innovations are breakthroughs related to antibodies that specifically bind to TL1A. One notable invention is a set of recombinantly expressed variant antibodies with enhanced affinity for TL1A. These antibodies provide potential treatments for a wide range of gastrointestinal diseases, including Crohn's disease, ulcerative colitis, and irritable bowel syndrome. Another significant patent involves anti-CXCR2 antibodies that act as selective antagonists, preventing neutrophil recruitment into tissues while preserving circulating neutrophil counts. These advancements demonstrate Pollard's commitment to addressing critical health issues through innovative scientific solutions.

Career Highlights

Pollard has garnered invaluable experience working with several prominent companies, including Cephalon, Inc. and Teva Pharmaceuticals Australia Pty Ltd. His work in these organizations has allowed him to foster a deep understanding of drug development and patent processes, enhancing his capability as an inventor.

Collaborations

Throughout his career, Pollard has collaborated with key individuals in the field, including Adam Clarke and Anthony Gerard Doyle. These partnerships have facilitated the exchange of ideas and expertise, resulting in further advancements in his research and development efforts.

Conclusion

Matthew Pollard's innovations play a crucial role in advancing therapeutic options for debilitating diseases. With his extensive experience and collaborative spirit, he continues to push the boundaries of biotechnology, offering hope for improved treatments in gastrointestinal and respiratory health. His work is a testament to the impact that dedicated inventors can have on the medical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…